These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7518662)
1. Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis. Xu H; Geddes R; Roberts-Thomson PJ Ann Rheum Dis; 1994 Jun; 53(6):383-90. PubMed ID: 7518662 [TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of CD5 B cells in patients with rheumatoid arthritis and essential mixed cryoimmunoglobulinemia using FACS analyzer and FACSCAN flow cytometer. Xu HJ; Roberts-Thomson PJ; Ahern MJ; Zola H Ann N Y Acad Sci; 1992 May; 651():594-8. PubMed ID: 1376088 [TBL] [Abstract][Full Text] [Related]
3. Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases. Roberts-Thomson PJ; Wernick RM; Ziff M Arthritis Rheum; 1981 Jun; 24(6):795-802. PubMed ID: 6972766 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue. Brown CM; Longhurst C; Haynes G; Plater-Zyberk C; Malcolm A; Maini RN Clin Exp Immunol; 1992 Aug; 89(2):230-8. PubMed ID: 1379132 [TBL] [Abstract][Full Text] [Related]
5. In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis. Nonaka S; Yasuda M; Nobunaga M J Rheumatol; 1993 Sep; 20(9):1478-84. PubMed ID: 7513025 [TBL] [Abstract][Full Text] [Related]
6. IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis. Hidaka T; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishizuka T; Kawagoe M; Nakamura H Clin Exp Immunol; 1992 Aug; 89(2):223-9. PubMed ID: 1379131 [TBL] [Abstract][Full Text] [Related]
7. Increase in CD5+ B cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity. Jarvis JN; Kaplan J; Fine N Arthritis Rheum; 1992 Feb; 35(2):204-7. PubMed ID: 1370899 [TBL] [Abstract][Full Text] [Related]
8. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878 [TBL] [Abstract][Full Text] [Related]
9. Pokeweed mitogen-induced secretion of IgG- and IgM-rheumatoid factors by synovial fluid and blood B lymphocytes in rheumatoid arthritis. Petersen J; Heilmann C; Høier-Madsen M Rheumatol Int; 1986; 6(3):115-20. PubMed ID: 3489273 [TBL] [Abstract][Full Text] [Related]
10. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals. Jasin HE Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929 [TBL] [Abstract][Full Text] [Related]
11. Large quantities of low molecular weight IgM in mixed cryoglobulinaemia. Roberts-Thomson PJ; Kennedy A; Koh LY Ann Rheum Dis; 1988 Feb; 47(2):105-9. PubMed ID: 3355247 [TBL] [Abstract][Full Text] [Related]
12. The rheumatoid factor cross-reactive idiotype in juvenile rheumatoid arthritis: role of the CD5-positive B cell. Ilowite NT; Wedgwood JF; Ramakrishnan T; Bonagura VR Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 2):S74-82. PubMed ID: 7684662 [TBL] [Abstract][Full Text] [Related]
13. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally. Jones BM; Cheng IK; Wong RW Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638 [TBL] [Abstract][Full Text] [Related]
14. Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients. Burastero SE; Cutolo M; Dessì V; Celada F Scand J Immunol; 1990 Oct; 32(4):347-57. PubMed ID: 1700467 [TBL] [Abstract][Full Text] [Related]
15. Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis. Koopman WJ; Schrohenloher RE Arthritis Rheum; 1980 Sep; 23(9):985-92. PubMed ID: 6968215 [TBL] [Abstract][Full Text] [Related]
16. IgM rheumatoid factor elaboration by blood, bone marrow, and synovial mononuclear cells in patients with rheumatoid arthritis. Panush RS; Bittner AK; Sullivan M; Katz P; Longley S Clin Immunol Immunopathol; 1985 Mar; 34(3):387-91. PubMed ID: 3871679 [TBL] [Abstract][Full Text] [Related]
17. Stimulatory effect of CD5 antibody on B cells from patients with rheumatoid arthritis. Hara M; Kitani A; Hirose T; Norioka K; Harigai M; Suzuki K; Tabata H; Kawakami M; Kawagoe M; Nakamura H Clin Immunol Immunopathol; 1988 Nov; 49(2):223-30. PubMed ID: 2458873 [TBL] [Abstract][Full Text] [Related]
18. The major rheumatoid factor cross-reactive idiotype is dominantly expressed by Staphylococcus aureus Cowan strain I-activated CD5+ control B cells. Bonagura VR; Pernis B; Agostino N; Hatam L Cell Immunol; 1992 Apr; 140(2):381-9. PubMed ID: 1371948 [TBL] [Abstract][Full Text] [Related]
19. Detection of low molecular weight IgM by immunoblot analysis in rheumatoid arthritis. Ezaki I; Shingu M; Nobunaga M; Otsuka E J Rheumatol; 1987 Aug; 14(4):674-9. PubMed ID: 3668973 [TBL] [Abstract][Full Text] [Related]
20. In vivo T cell depletion in rheumatoid arthritis is associated with increased in vitro IgM-rheumatoid factor synthesis. Olsen NJ; Teal GP; Strand V Clin Immunol Immunopathol; 1993 May; 67(2):124-9. PubMed ID: 7686090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]